secwatch / observer
8-K filed January 12, 2026, 6:59 PM ET ticker IVPR CIK 0001939365
debt confidence high sentiment negative materiality 0.65

INSPIRE VETERINARY PARTNERS, INC. (IVPR): debt financing — Inspire Veterinary issues $975K convertible note at 23% OID, 10% interest; director resigns

INSPIRE VETERINARY PARTNERS, INC.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

INSPIRE VETERINARY PARTNERS, INC. incurred convertible notes of up to an aggregate of $1,626,000 principal amount of convertible promissory notes with Manetto Hill Fund Series I LLC.

Instrument
convertible notes
Principal
up to an aggregate of $1,626,000 principal amount of convertible promissory notes
Counterparty
Manetto Hill Fund Series I LLC
Event
incurrence
Exact text from the filing
On January 6, 2026, effective as of December 31, 2025, Inspire Veterinary Partners, Inc. (the "Company") entered into a securities purchase agreement with Manetto Hill Fund Series I LLC, a Delaware limited liability company ("Manetto") whereby the Company may issue up to an aggregate of $1,626,000 principal amount of convertible promissory notes in one or more closings, subject to the terms and conditions set forth therein.
View on SEC.gov
Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

INSPIRE VETERINARY PARTNERS, INC. incurred convertible notes of $975,000 with Manetto Hill Fund Series I LLC at 10% per annum maturing December 31, 2026.

Instrument
convertible notes
Principal
$975,000
Counterparty
Manetto Hill Fund Series I LLC
Rate
10% per annum
Maturity
December 31, 2026
Event
incurrence
Exact text from the filing
On January 6, 2026, effective as of December 31, 2025, the Company issued to a secured convertible promissory note in the principal amount of $975,000 for a purchase price of $750,000 (the "Note").
View on SEC.gov
Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

INSPIRE VETERINARY PARTNERS, INC. issued convertible note to Manetto Hill Fund Series I LLC for $975,000 principal amount for a purchase price of $750,000.

Security
convertible note
Purchaser
Manetto Hill Fund Series I LLC
Consideration
$975,000 principal amount for a purchase price of $750,000
Exact text from the filing
On January 6, 2026, effective as of December 31, 2025, the Company issued to a secured convertible promissory note in the principal amount of $975,000 for a purchase price of $750,000 (the “Note”).
View on SEC.gov
Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

INSPIRE VETERINARY PARTNERS, INC. issued up to 2,500,000 shares of common stock of common stock to Manetto Hill Fund Series I LLC.

Security
common stock
Shares
up to 2,500,000 shares of common stock
Purchaser
Manetto Hill Fund Series I LLC
Exact text from the filing
Pursuant to the securities purchase agreement, in connection with the issuance of the Note, the Company agreed to issue up to 2,500,000 shares of common stock to Manetto (the “Commitment Shares”).
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

INSPIRE VETERINARY PARTNERS, INC. entered into securities purchase agreement with Manetto Hill Fund Series I LLC valued at up to an aggregate of $1,626,000 principal amount of convertible promissory notes (effective 2026-01-06).

Action
entry
Agreement
equity purchase
Counterparty
Manetto Hill Fund Series I LLC
Value
up to an aggregate of $1,626,000 principal amount of convertible promissory notes
Effective
2026-01-06
Exact text from the filing
On January 6, 2026, effective as of December 31, 2025, Inspire Veterinary Partners, Inc. (the “Company”) entered into a securities purchase agreement with Manetto Hill Fund Series I LLC
View on SEC.gov

26 debt financings filed in the last 30 days. Browse all debt financings →

INSPIRE VETERINARY PARTNERS, INC. filing history →

Source: SEC EDGAR
accession 0001213900-26-003112
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.